NCT02240160
A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2014
Completion: Oct 31, 2015